Hyperfine (HYPR) Gross Profit Growth (1y) (2022 - 2026)
Hyperfine (HYPR) Gross Profit Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.41% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 15.74% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.30% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 27.39% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -1.74% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.72% |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn | 124.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.12% |
| Dec 31, 2025 | 226.15% |
| Sep 30, 2025 | -3.14% |
| Jun 30, 2025 | -26.34% |
| Mar 31, 2025 | -34.79% |
| Dec 31, 2024 | -20.12% |
| Sep 30, 2024 | 69.75% |
| Jun 30, 2024 | 24.86% |
| Mar 31, 2024 | 17.23% |
| Dec 31, 2023 | 244.67% |
| Sep 30, 2023 | 63.37% |
| Jun 30, 2023 | 975.15% |
| Mar 31, 2023 | 1,275.00% |
| Dec 31, 2022 | 166.23% |
| Sep 30, 2022 | 303.55% |
| Jun 30, 2022 | -66.67% |
| Mar 31, 2022 | 130.32% |